Sascha Dublin to Young Adult
This is a "connection" page, showing publications Sascha Dublin has written about Young Adult.
Connection Strength
0.843
-
Antidepressant continuation in pregnancy and risk of gestational diabetes. Pharmacoepidemiol Drug Saf. 2019 09; 28(9):1194-1203.
Score: 0.105
-
Getting through the day: a pilot qualitative study of U.S. women's experiences making decisions about anti-nausea medication during pregnancy. BMC Pregnancy Childbirth. 2018 Dec 04; 18(1):475.
Score: 0.101
-
Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. Int J Drug Policy. 2017 08; 46:90-98.
Score: 0.091
-
Linking mothers and infants within electronic health records: a comparison of deterministic and probabilistic algorithms. Pharmacoepidemiol Drug Saf. 2015 Jan; 24(1):45-51.
Score: 0.076
-
Methods of linking mothers and infants using health plan data for studies of pregnancy outcomes. Pharmacoepidemiol Drug Saf. 2013 Jul; 22(7):776-82.
Score: 0.068
-
Natural Language Processing to identify pneumonia from radiology reports. Pharmacoepidemiol Drug Saf. 2013 Aug; 22(8):834-41.
Score: 0.068
-
Population-Based Signals of Antidepressant Drug Interactions Associated With Unintentional Traumatic Injury. Clin Pharmacol Ther. 2021 08; 110(2):409-423.
Score: 0.030
-
Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury. Biomed Pharmacother. 2020 Oct; 130:110531.
Score: 0.028
-
Impact of an opioid risk reduction initiative on motor vehicle crash risk among chronic opioid therapy patients. Pharmacoepidemiol Drug Saf. 2017 01; 26(1):47-55.
Score: 0.022
-
Birth Weight and Birth Weight for Gestational Age in Relation to Risk of Hospitalization with Primary Hypertension in Children and Young Adults. Matern Child Health J. 2016 07; 20(7):1415-23.
Score: 0.021
-
Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies. Pharmacoepidemiol Drug Saf. 2016 Feb; 25(2):170-8.
Score: 0.020
-
The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy. J Pain. 2016 Jan; 17(1):101-10.
Score: 0.020
-
Prehypertension prior to or during early pregnancy is associated with increased risk for hypertensive disorders in pregnancy and gestational diabetes. J Hypertens. 2015 Sep; 33(9):1860-7; discussion 1867.
Score: 0.020
-
Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain. J Womens Health (Larchmt). 2015 Aug; 24(8):629-35.
Score: 0.020
-
The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J. 2014 Jan; 18(1):64-72.
Score: 0.018
-
Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J. 2013 Nov; 17(9):1611-21.
Score: 0.018
-
Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):488-95.
Score: 0.017
-
Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries. Arch Womens Ment Health. 2013 Apr; 16(2):149-57.
Score: 0.017
-
Validation of an algorithm to estimate gestational age in electronic health plan databases. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):524-32.
Score: 0.017
-
Prevalence, trends, and patterns of use of antidiabetic medications among pregnant women, 2001-2007. Obstet Gynecol. 2013 Jan; 121(1):106-14.
Score: 0.017
-
Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol. 2012 Nov; 26(6):578-88.
Score: 0.017
-
Medication Exposure in Pregnancy Risk Evaluation Program. Matern Child Health J. 2012 Oct; 16(7):1349-54.
Score: 0.016
-
Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):138-45.
Score: 0.014